Effect of polar lipids on cerebral content of free glucose in mice.
D000596:Amino Acids / Q000502:physiology; D000654:Amobarbital / Q000494:pharmacology; D000661:Amphetamine / Q000494:pharmacology; D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D001812:Blood-Brain Barrier; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D002554:Cerebrosides / Q000502:physiology; D002784:Cholesterol / Q000502:physiology; D004088:Dihydroergotoxine / Q000494:pharmacology; D004837:Epinephrine / Q000494:pharmacology; D005215:Fasting; D005227:Fatty Acids / Q000502:physiology; D005947:Glucose / Q000378:metabolism*; D007016:Hypophysectomy; D007328:Insulin / Q000494:pharmacology; D008012:Lidocaine / Q000494:pharmacology; D008055:Lipids / Q000494:pharmacology / Q000502:physiology*; D051379:Mice; D008954:Models, Biological; D010743:Phospholipids / Q000502:physiology
D000596:Amino Acids; D001786:Blood Glucose; D002554:Cerebrosides; D005227:Fatty Acids; D007328:Insulin; D008055:Lipids; D010743:Phospholipids; D004088:Dihydroergotoxine; D002784:Cholesterol; D008012:Lidocaine; D000661:Amphetamine; D000654:Amobarbital; D005947:Glucose; D004837:Epinephrine